A recent study [100] reported a heterogeneous PD-L1 expression in primary breast cancer tissues, which are generally associated with the presence of tumor-infiltrating lymphocytes and poor-prognostic features such as high grade, and aggressive molecular subtypes (TNBC, basal, HER2+). Here, CD274 is linked to breast cancer.